Literature DB >> 6824249

The cimetidine-lidocaine interaction.

A B Knapp, W Maguire, G Keren, A Karmen, B Levitt, D S Miura, J C Somberg.   

Abstract

Lidocaine is a widely used antiarrhythmic agent whose plasma clearance varies with changes in hepatic blood flow. Cimetidine, an H2-receptor antagonist, has been shown to decrease hepatic blood flow. To ascertain whether cimetidine affected serum lidocaine concentration, we studied 21 patients receiving lidocaine infusions and divided them into two groups. Fifteen patients received cimetidine, 300 mg every 6 hours, in addition to lidocaine; six patients received only lidocaine. In 14 of the 15 patients receiving both lidocaine and cimetidine, a rise in serum lidocaine levels was seen, whereas no change was noted in the control group. Six of the 15 patients were found to have levels in the toxic range and two had symptoms. An additional three patients on lidocaine received diphenhydramine, an H1-receptor antagonist. No elevation in serum lidocaine levels was noted after administration of diphenhydramine. We conclude that there exists an interaction between lidocaine and cimetidine and that the rise in serum lidocaine levels may be mediated by cimetidine's inhibition of the H2 receptor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824249     DOI: 10.7326/0003-4819-98-2-174

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  17 in total

Review 1.  Clinical relevance of cimetidine drug interactions.

Authors:  A F Shinn
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

2.  Drug interactions through binding to cytochrome p 450: the experience with h2-receptor blocking agents.

Authors:  U Klotz; I W Reimann
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

3.  Local anesthetics: a century of progress.

Authors:  J A Yagiela
Journal:  Anesth Prog       Date:  1985 Mar-Apr

Review 4.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

5.  H2 receptor antagonists: cimetidine and ranitidine.

Authors:  J R Wood
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-30

6.  Lack of effect of cimetidine on the pharmacokinetics of bupivacaine in healthy subjects.

Authors:  K K Pihlajamäki; R L Lindberg; M E Jantunen
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

7.  Pitfalls and perils of intravenous lidocaine.

Authors:  C A Bryant; J R Hoffman; L S Nichter
Journal:  West J Med       Date:  1983-10

8.  Cimetidine-induced alterations in desipramine plasma concentrations.

Authors:  J D Amsterdam; D J Brunswick; L Potter; M J Kaplan
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Effect of cimetidine on digoxin disposition in peptic ulcer patients.

Authors:  M Garty; G Perry; H Shmueli; D Ilfeld; G Boner; S Pitlik; J Rosenfeld
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 10.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.